Citadel Advisors’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-141,229
Closed -$91.9K 6936
2025
Q1
$91.9K Sell
141,229
-2,317,428
-94% -$1.51M ﹤0.01% 5183
2024
Q4
$4.52M Buy
2,458,657
+332,002
+16% +$611K ﹤0.01% 1884
2024
Q3
$7.36M Buy
2,126,655
+506,748
+31% +$1.75M ﹤0.01% 1470
2024
Q2
$4.75M Buy
1,619,907
+1,279,166
+375% +$3.75M ﹤0.01% 1719
2024
Q1
$1.93M Buy
340,741
+208,816
+158% +$1.18M ﹤0.01% 2527
2023
Q4
$566K Buy
131,925
+83,336
+172% +$358K ﹤0.01% 3606
2023
Q3
$169K Buy
48,589
+20,261
+72% +$70.3K ﹤0.01% 4624
2023
Q2
$132K Sell
28,328
-300,840
-91% -$1.4M ﹤0.01% 4627
2023
Q1
$1.52M Buy
329,168
+209,166
+174% +$966K ﹤0.01% 2778
2022
Q4
$970K Sell
120,002
-182,090
-60% -$1.47M ﹤0.01% 3233
2022
Q3
$1.68M Sell
302,092
-313,607
-51% -$1.74M ﹤0.01% 2914
2022
Q2
$3.21M Buy
615,699
+257,854
+72% +$1.34M ﹤0.01% 2289
2022
Q1
$2.94M Sell
357,845
-238,925
-40% -$1.96M ﹤0.01% 2588
2021
Q4
$8.88M Sell
596,770
-72,873
-11% -$1.08M ﹤0.01% 1560
2021
Q3
$12.7M Sell
669,643
-90,351
-12% -$1.71M ﹤0.01% 1221
2021
Q2
$14.1M Sell
759,994
-216,626
-22% -$4.03M ﹤0.01% 1192
2021
Q1
$22.2M Sell
976,620
-316,384
-24% -$7.2M 0.01% 867
2020
Q4
$28.1M Buy
1,293,004
+72,879
+6% +$1.58M 0.01% 684
2020
Q3
$12.3M Sell
1,220,125
-51,398
-4% -$517K ﹤0.01% 997
2020
Q2
$9.87M Sell
1,271,523
-277,831
-18% -$2.16M ﹤0.01% 1091
2020
Q1
$15.8M Sell
1,549,354
-179,622
-10% -$1.83M 0.01% 760
2019
Q4
$19M Sell
1,728,976
-828
-0% -$9.11K 0.01% 826
2019
Q3
$15.7M Buy
1,729,804
+1,459
+0.1% +$13.3K 0.01% 930
2019
Q2
$19.7M Sell
1,728,345
-858
-0% -$9.76K 0.01% 815
2019
Q1
$19.7M Buy
1,729,203
+160
+0% +$1.82K 0.01% 753
2018
Q4
$15.6M Sell
1,729,043
-19,378
-1% -$175K 0.01% 786
2018
Q3
$26.2M Buy
+1,748,421
New +$26.2M 0.01% 638